Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

RxSight (RXST) Income from Continuing Operations (2020 - 2026)

RxSight filings provide 6 years of Income from Continuing Operations readings, the most recent being 9152000.0 for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations fell 142.63% to 9152000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 38944000.0, a 79377.55% decrease, with the full-year FY2025 number at 38944000.0, down 79377.55% from a year prior.
  • Income from Continuing Operations hit 9152000.0 in Q4 2025 for RxSight, up from 9816000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 32960000.0 in Q4 2021 to a low of 17596000.0 in Q1 2022.
  • Median Income from Continuing Operations over the past 5 years was 10801000.0 (2025), compared with a mean of 7717700.0.
  • Biggest five-year swings in Income from Continuing Operations: tumbled 158.57% in 2022 and later skyrocketed 333.88% in 2024.
  • RxSight's Income from Continuing Operations stood at 32960000.0 in 2021, then tumbled by 147.36% to 15610000.0 in 2022, then skyrocketed by 41.2% to 9179000.0 in 2023, then skyrocketed by 333.88% to 21468000.0 in 2024, then plummeted by 142.63% to 9152000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 9152000.0 (Q4 2025), 9816000.0 (Q3 2025), and 11786000.0 (Q2 2025) per Business Quant data.